BS EN ISO 10993-11:2018:2022 Edition
$189.07
Biological evaluation of medical devices – Tests for systemic toxicity
Published By | Publication Date | Number of Pages |
BSI | 2022 | 46 |
PDF Catalog
PDF Pages | PDF Title |
---|---|
2 | National foreword |
6 | European foreword |
7 | Annex ZA (informative) Relationship between this European Standard and the essential requirements of Directive 93/42/EEC [OJ L 169] aimed to be covered |
10 | Annex ZB (informative) Relationship between this European Standard and the essential requirements of Directive 90/385/EEC [OJ L 189] aimed to be covered |
14 | Foreword |
15 | Introduction |
17 | 1 Scope 2 Normative references 3 Terms and definitions |
19 | 4 General considerations 4.1 General 4.2 Selection of animal species 4.3 Animal status 4.4 Animal care and husbandry |
20 | 4.5 Size and number of groups 4.5.1 Size of groups 4.5.2 Number of groups 4.5.3 Treatment controls |
21 | 4.6 Route of exposure 4.7 Sample preparation 4.8 Dosing 4.8.1 Test sample administration 4.8.2 Dosage volumes |
22 | 4.8.3 Dosage frequency 4.9 Body weight and food/water consumption 4.10 Clinical observations 4.11 Clinical pathology |
23 | 4.12 Anatomic pathology 4.13 Study designs 4.14 Quality of investigation 5 Acute systemic toxicity 5.1 General |
24 | 5.2 Study design 5.2.1 Preparations 5.2.2 Experimental animals 5.2.3 Test conditions |
25 | 5.2.4 Body weights 5.2.5 Clinical observations 5.2.6 Pathology |
26 | 5.3 Evaluation criteria 5.3.1 General 5.3.2 Evaluation of results 5.4 Final report |
28 | 6 Repeated exposure systemic toxicity (subacute, subchronic and chronic systemic toxicity) 6.1 General 6.2 Study design 6.2.1 Preparations 6.2.2 Experimental animals |
29 | 6.2.3 Test conditions 6.2.4 Body weights 6.2.5 Clinical observations 6.2.6 Pathology |
30 | 6.3 Evaluation criteria 6.3.1 General |
31 | 6.3.2 Evaluation of results 6.4 Final report |
32 | Annex A (informative) Routes of administration |
34 | Annex B (informative) Dosage volumes |
35 | Annex C (informative) Common clinical signs and observations |
36 | Annex D (informative) Suggested haematology, clinical chemistry and urinalysis measurements |
38 | Annex E (informative) Suggested organ list for histopathological evaluation |
40 | Annex F (informative) Organ list for limited histopathology for medical devices subjected to systemic toxicity testing |
41 | Annex G (informative) Information on material-mediated pyrogens |
42 | Annex H (informative) Subchronic rat — Dual routes of parenteral administration |
44 | Bibliography |